Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Cybin Inc. (CYBN) is a stock that can certainly grab the attention of many investors ...
We recently compiled a list of the 12 Best Psychedelic Stocks to Buy in 2025. In this article, we are going to take a look at where Cybin Inc. (NYSEAMERICAN:CYBN) stands against the other psychedelic ...
The United States Patent and Trademark Office (USPTO) has granted U.S. patent 12,122,741, which claims the composition of matter of lead preclinical candidates in Cybin Inc’s (NYSE:CYBN) CYB005 ...
We recently compiled a list of the 13 Best Psychedelic Stocks to Invest in Now. Cybin Inc. is one of them. Cybin Inc. (NYSE:CYBN) is a clinical-stage neuropsychiatry company developing ...
Cybin ( (TSE:CYBN)) has issued an update. Cybin Inc. will transfer its U.S. stock market listing from NYSE American to the Nasdaq Global Market, with trading on NYSE American ending on January 2, 2026 ...
(the “Company”) doing business as Helus Pharma ™ (Nasdaq: HELP) (Cboe CA: HELP) (“Helus Pharma”), a clinical stage pharmaceutical company committed to helping minds heal by developing NSAs, today ...
Cybin Inc. (CYBN) closed the last trading session at $8.46, gaining 7.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results